Recombinantly produced human factor VIII and IX

US9120873B2 · kind B2 · utility

Assignee

• OCTAPHARMA AG · CH

Inventors

• Helena Sandberg · Vingåker, SE
• Peter Stenlund · Stockholm, SE
• Carola Schröder · Munich, DE
• Elisabeth Casademunt · Birkenfeld, DE
• Maya Tiemeyer · Ladenburg, DE

Key dates

• Filing date: Aug 21, 2009
• Grant date: Sep 1, 2015
• Expiry date: Oct 7, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A recombinant human factor VIII or IX protein having a human glycosylation pattern but the protein is devoid of N-glycolylneuraminic acid and/or the carbohydrate group Galα-3Gal.